Chicago Research Center Inc.

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Obstructive sleep apnoea5 trials
• Obesity2 trials
• Depression1 trial
• High blood pressure1 trial

Phase

• Phase 35 trials
• Phase 22 trials

Status

• Completed4 trials
• Enrolling by invitation1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Apnimed3 trials
• Novo Nordisk A/S2 trials
• Mineralys Therapeutics Inc.1 trial
• Suven Life Sciences Limited1 trial

Running trials

• Recruiting

  A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  NCT07668414· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571109· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Enrolling by invitation

  Continuation Protocol for Obstructive Sleep Apnea (OSA)

  NCT06566820· Phase 3· Apnimed· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Obstructive sleep apnoea2 recruiting

Closed trials

• Completed

  Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients

  NCT06836063· Phase 2· Suven Life Sciences Limited· Source

• Completed

  A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension

  NCT06785454· Phase 2· Mineralys Therapeutics Inc.· Source

• Completed

  Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

  NCT05813275· Phase 3· Apnimed· Source

• Completed

  Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

  NCT05811247· Phase 3· Apnimed· Source